Hughson M D, Meloni A M, Silva F G, Sandberg A A
Department of Veterans Affairs Medical Center, Northport, NY 11768-2290, USA.
Cancer Genet Cytogenet. 1996 Jul 1;89(1):65-8. doi: 10.1016/0165-4608(95)00353-3.
Renal cell carcinomas (RCCs) occur at an increased rate and at a younger age in patients with end-stage renal disease (ESRD) than in the general population. A papillary RCC from a patient with ESRD treated by hemodialysis and then by renal transplantation was karyotyped and showed a 55,XY,+2,+4,+7,+10,+12,+16,+17,+17,+20 mainline. No loss of gene sequences in the short arm of chromosome 3 was identified by chromosomal or molecular genetic analysis. Together with one prior report of a cytogenetic study of a RCC in an end-stage kidney, the findings indicate that papillary RCCs that arise in ESRD patients have genetic changes that are similar to those found in sporadic tumors. The increased frequency of tumors and the younger age of the patients may be due to an increased rate at which abnormal mitoses occur in diseased renal tissues.
与普通人群相比,终末期肾病(ESRD)患者肾细胞癌(RCC)的发病率更高且发病年龄更小。对一名接受血液透析后又接受肾移植治疗的ESRD患者的乳头状RCC进行了核型分析,结果显示其主要核型为55,XY,+2,+4,+7,+10,+12,+16,+17,+17,+20。通过染色体或分子遗传学分析未发现3号染色体短臂上的基因序列缺失。结合之前一篇关于终末期肾病患者RCC细胞遗传学研究的报告,这些发现表明,ESRD患者中出现的乳头状RCC具有与散发性肿瘤相似的基因变化。肿瘤发病率的增加以及患者年龄的年轻化可能是由于患病肾组织中异常有丝分裂发生率增加所致。